Beta-blockade and growth hormone after burn.

David W Hart, Steven E Wolf, David L Chinkes, Sofia O Lal, Peter I Ramzy, David N Herndon

Journal: Annals of surgery 2002;236(4):450-6; discussion 456-7

PMID: 12368673

Abstract

OBJECTIVE

To determine whether propranolol and growth hormone (GH) have additive effects to combat burn-induced catabolism.

SUMMARY BACKGROUND DATA

Both GH and propranolol have been attributed anabolic properties after severe trauma and burn. It is conceivable that the two in combination would have additive effects.

METHODS

Fifty-six children with more than 40% TBSA burns were randomized to one of four anabolic regimens: untreated control, GH treatment, propranolol treatment, or combination GH plus propranolol therapy. Clinical treatment was identical for all groups. Resting energy expenditure was determined by indirect calorimetry and skeletal muscle protein kinetics were measured using stable amino acid isotope infusions before and after each anabolic regimen.

RESULTS

There were no differences in age, sex, or burn size between groups. Tachycardia and energy expenditure were decreased during propranolol treatment ( <.05). The net balance of muscle protein synthesis and breakdown was improved during propranolol and GH plus propranolol treatment ( <.05). There was no significant benefit of GH alone. No additive effect of combination therapy was seen.

CONCLUSIONS

Propranolol is a strongly anabolic drug during the early, hypercatabolic period after burn. No synergistic effect between propranolol and GH was identified.

Address: Department of Surgery, The University of Texas Medical Branch, Shriners Hospitals for Children, Galveston, Texas 77550, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.